Compounded GLP-1 by medication.

Compounded semaglutide costs from $149 a month, the floor GLP Chart tracks across US telehealth programs, checked August 31, 2026. A licensed pharmacy makes compounded GLP-1 against a prescription. The FDA has not approved it and it is not Wegovy, Ozempic or Zepbound. Branded Wegovy lists at $1,349. We index the programs below by formulation, compounded semaglutide or compounded tirzepatide. The full cross-program price comparison is in the GLP-1 price index.

A note on safety. Compounded GLP-1 is prescribed under medical necessity, and the pharmacy behind it matters. Every program below uses a 503A or 503B facility under US state pharmacy-board licensure. We tried to source the pharmacy behind each program. Only two of 13 name it. See the sourced breakdown.

Compounded GLP-1 prescribing has narrowed. The FDA removed semaglutide from its drug-shortage list in February 2025 and tirzepatide in October 2024, and many programs that once offered compounded have since exited. The programs below are the ones still active. For the legal and safety picture, see whether compounded semaglutide is legit and safe.

Cash-pay compounded semaglutide runs from roughly $149 to $397 a month (Strut Health at $99 is an oral lozenge, not an injection). Compounded tirzepatide runs $278 to $524. For pricing context across the full market, see the GLP-1 cost guide and the ranked list of best compounded GLP-1 programs.

Compounded semaglutide

8 programs in our chart prescribes this.